Clinical Trial

Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Efficacy and Safety of Nitazoxanide in preventing recurrence of Hepatic Encephalopathy.
Trial Details
NCT Number NCT04161053
Lead Sponsor Tanta University
Conditions Hepatic Encephalopathy
Enrollment 60 participants
Start Date 2018-11-01
Primary Completion 2028-11 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2019-11-13